Subsequently, populations of CD24+CD29+ cells and CD24+CD49f+ cells were isolated from BRCA1-mutated mammary tumors and displayed self-renewal and tumor-initiating capacity in vivo [15]. This evidence concerns the gene BRCA1 and breast cancer.